Hikma Pharmaceuticals PLC
LSE:HIK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
UK |
|
Parker-Hannifin Corp
NYSE:PH
|
US |
|
G
|
G-III Apparel Group Ltd
F:GI4
|
US |
|
C
|
Cummins Inc
LSE:0I58
|
US |
|
Mr DIY Group (M) Bhd
OTC:MDIYF
|
MY |
|
B
|
Bollore SE
XMUN:BOP
|
FR |
|
Heineken NV
AEX:HEIA
|
NL |
|
Siemens Healthineers AG
F:SHL
|
DE |
|
Indah Kiat Pulp & Paper Tbk PT
IDX:INKP
|
ID |
|
Holcim AG
F:HLBN
|
CH |
|
Eagle Materials Inc
F:E5M
|
US |
|
Banco Santander SA
F:BSD2
|
ES |
|
C
|
Currys PLC
DUS:CWB
|
UK |
|
F
|
Ford Motor Co
XETRA:FMC1
|
US |
|
NetEase Inc
NASDAQ:NTES
|
CN |
|
Five Star Bancorp
F:4F6
|
US |
|
Smith & Nephew PLC
OTC:SNNUF
|
UK |
|
O
|
Okinawa Cellular Telephone Co
XMUN:OCU
|
JP |
|
LG Electronics Inc
KRX:066570
|
KR |
|
Sampo Oyj
F:SMP0
|
FI |
|
Exelon Corp
NASDAQ:EXC
|
US |
|
C
|
CrowdStrike Holdings Inc
SWB:45C
|
US |
|
Brambles Ltd
ASX:BXB
|
AU |
|
Grupo Aeroportuario del Pacifico SAB de CV
NYSE:PAC
|
MX |
Bankruptcy Probability
Hikma Pharmaceuticals PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hikma Pharmaceuticals PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
3.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
648.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
369.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
354B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
194.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
304.3B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
127.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hikma Pharmaceuticals PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hikma Pharmaceuticals PLC has total debt of 1.5B USD. This includes both short-term (0 USD) and long-term (1.5B USD) debt.
You can find a full breakdown on its Balance Sheet.